Total Payments
$4,087
2024 Payments
$881.52
Companies
13
Transactions
70
Medicare Patients
9,789
Medicare Billing
$845,160
Payment Breakdown by Category
Other$2,956 (72.3%)
Food & Beverage$1,032 (25.2%)
Education$99.00 (2.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,956 | 25 | 72.3% |
| Food and Beverage | $1,032 | 44 | 25.2% |
| Education | $99.00 | 1 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $2,240 | 17 | $0 (2023) |
| ABBVIE INC. | $846.97 | 17 | $0 (2024) |
| Janssen Biotech, Inc. | $238.26 | 9 | $0 (2024) |
| Amgen Inc. | $114.65 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $105.56 | 7 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $102.72 | 2 | $0 (2023) |
| UCB, Inc. | $102.17 | 3 | $0 (2024) |
| PFIZER INC. | $81.03 | 1 | $0 (2023) |
| Incyte Corporation | $70.92 | 2 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $69.82 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $881.52 | 22 | ABBVIE INC. ($543.63) |
| 2023 | $825.86 | 24 | ABBVIE INC. ($285.27) |
| 2022 | $1,188 | 9 | Allergan, Inc. ($1,132) |
| 2021 | $1,036 | 11 | Allergan, Inc. ($993.45) |
| 2018 | $155.33 | 4 | Janssen Scientific Affairs, LLC ($69.82) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $36.00 | General |
| 10/04/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $243.00 | General |
| 09/06/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $96.00 | General |
| 07/23/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Dermatology | ||||||
| 07/02/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $75.00 | General |
| 06/25/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Dermatology | ||||||
| 06/12/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $26.22 | General |
| Category: Inflammation | ||||||
| 06/06/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $36.00 | General |
| 05/15/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: DERMATOLOGY | ||||||
| 05/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Immunology | ||||||
| 05/06/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $48.00 | General |
| 04/18/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Dermatology | ||||||
| 04/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 04/10/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $33.27 | General |
| Category: Inflammation | ||||||
| 03/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Immunology | ||||||
| 03/14/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: DERMATOLOGY | ||||||
| 03/08/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Dermatology | ||||||
| 02/08/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Dermatology | ||||||
| 02/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.63 | General |
| Category: IMMUNOLOGY | ||||||
| 01/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Immunology | ||||||
| 01/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Dermatology | ||||||
| 01/09/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Immunology | ||||||
| 12/19/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Immunology | ||||||
| 12/05/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Dermatology | ||||||
| 11/02/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,783 | 4,889 | $336,755 | $231,599 |
| 2022 | 20 | 2,426 | 4,187 | $301,392 | $211,705 |
| 2021 | 24 | 2,399 | 4,104 | $332,296 | $225,028 |
| 2020 | 19 | 2,181 | 3,688 | $251,770 | $176,828 |
Total Patients
9,789
Total Services
16,868
Medicare Billing
$845,160
Procedure Codes
84
All Medicare Procedures & Services
84 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 1,060 | 1,582 | $118,728 | $87,810 | 74.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 489 | 707 | $66,071 | $44,445 | 67.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 199 | 240 | $25,864 | $17,310 | 66.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 287 | 388 | $27,360 | $15,910 | 58.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 64 | 100 | $17,568 | $13,153 | 74.9% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 31 | 32 | $10,326 | $7,284 | 70.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 230 | 1,350 | $10,806 | $6,860 | 63.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 33 | 41 | $7,622 | $5,158 | 67.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 64 | 92 | $4,876 | $3,584 | 73.5% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 11 | 11 | $4,727 | $3,370 | 71.3% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 27 | 33 | $5,082 | $3,362 | 66.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 67 | 73 | $4,234 | $2,979 | 70.4% |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 20 | 23 | $3,933 | $2,950 | 75.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 23 | 29 | $3,856 | $2,693 | 69.8% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 15 | 15 | $4,290 | $2,499 | 58.3% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 16 | 20 | $3,700 | $2,398 | 64.8% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 29 | 29 | $3,887 | $2,270 | 58.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 26 | 26 | $3,094 | $2,208 | 71.4% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2023 | 57 | 61 | $2,769 | $2,049 | 74.0% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 21 | 22 | $4,070 | $1,667 | 40.9% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 14 | 15 | $3,892 | $1,639 | 42.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 1,043 | 1,574 | $117,582 | $88,054 | 74.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 358 | 524 | $48,972 | $32,850 | 67.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 155 | 190 | $20,514 | $13,845 | 67.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 67 | 101 | $17,743 | $12,817 | 72.2% |
About Dr. Eric Rasmussen, MD
Dr. Eric Rasmussen, MD is a Dermatology healthcare provider based in Silverdale, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467423376.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Rasmussen, MD has received a total of $4,087 in payments from pharmaceutical and medical device companies, with $881.52 received in 2024. These payments were reported across 70 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($2,956).
As a Medicare-enrolled provider, Rasmussen has provided services to 9,789 Medicare beneficiaries, totaling 16,868 services with total Medicare billing of $845,160. Data is available for 4 years (2020–2023), covering 84 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Silverdale, WA
- Active Since 01/30/2006
- Last Updated 04/30/2020
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1467423376
Products in Payments
- TREMFYA (Drug) $218.32
- Otezla (Drug) $114.65
- COSENTYX (Drug) $105.56
- LITFULO (Drug) $81.03
- OPZELURA (Drug) $70.92
- Tremfya (Drug) $69.82
- SILIQ (Drug) $60.60
- Bimzelx (Biological) $59.51
- VTAMA (Drug) $53.94
- RINVOQ (Biological) $52.05
- SKYRIZI (Biological) $50.00
- Cimzia (Drug) $42.66
- TARGRETIN (Drug) $42.12
- ILUMYA (Biological) $35.55
- PICATO (Drug) $24.91
- REMICADE (Biological) $19.94
- BOTOX (Biological) $9.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.